AXCELLA HEALTH INC
Pagina dedicata companiei AXCELLA HEALTH INC listata cu simbolurile US.AXLA, US.AXLAc
Descriere companie[edit | ]
Axcella Health Inc. (www.axcellatx.com) is a biotechnology company. The Company is focused on treating diseases using endogenous metabolic modulator (EMM) compositions. Its product candidates are comprised of multiple EMMs. EMMs encompass a of molecular families, including amino acids, bile acids, other intermediary substrates, and hormones. The Company's product pipeline includes AXA1665 and AXA1125. Its product candidate AXA1665 is developed for for the Reduction in Risk of Overt Hepatic Encephalopathy (OHE) recurrence with liver cirrhosis. AXA1665 consist of eight amino acids to target multiple metabolic pathways intersecting key organ systems liver, muscle, and gut. Its other product candidate include AXA1125, which is developed or the treatment of Nonalcoholic Steatohepatitis (NASH).
Grafic actiuni companie[edit | ]